25 XP   0   0   10

Lee’s Pharmaceutical Holdings Ltd
Buy, Hold or Sell?

Let's analyse Lee’s Pharmaceutical Holdings Ltd together

PenkeI guess you are interested in Lee’s Pharmaceutical Holdings Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Lee’s Pharmaceutical Holdings Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Lee’s Pharmaceutical Holdings Ltd

I send you an email if I find something interesting about Lee’s Pharmaceutical Holdings Ltd.

Quick analysis of Lee’s Pharmaceutical Holdings Ltd (30 sec.)










What can you expect buying and holding a share of Lee’s Pharmaceutical Holdings Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.01
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
HK$3.33
Expected worth in 1 year
HK$3.58
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
HK$0.32
Return On Investment
27.8%

For what price can you sell your share?

Current Price per Share
HK$1.15
Expected price per share
HK$1 - HK$1.23
How sure are you?
50%

1. Valuation of Lee’s Pharmaceutical Holdings Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$1.15

Intrinsic Value Per Share

HK$-1.41 - HK$2.30

Total Value Per Share

HK$1.91 - HK$5.63

2. Growth of Lee’s Pharmaceutical Holdings Ltd (5 min.)




Is Lee’s Pharmaceutical Holdings Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$250.9m$246.2m$4.6m1.9%

How much money is Lee’s Pharmaceutical Holdings Ltd making?

Current yearPrevious yearGrowGrow %
Making money$2.1m$6.5m-$4.4m-207.1%
Net Profit Margin1.6%4.2%--

How much money comes from the company's main activities?

3. Financial Health of Lee’s Pharmaceutical Holdings Ltd (5 min.)




What can you expect buying and holding a share of Lee’s Pharmaceutical Holdings Ltd? (5 min.)

Welcome investor! Lee’s Pharmaceutical Holdings Ltd's management wants to use your money to grow the business. In return you get a share of Lee’s Pharmaceutical Holdings Ltd.

What can you expect buying and holding a share of Lee’s Pharmaceutical Holdings Ltd?

First you should know what it really means to hold a share of Lee’s Pharmaceutical Holdings Ltd. And how you can make/lose money.

Speculation

The Price per Share of Lee’s Pharmaceutical Holdings Ltd is HK$1.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lee’s Pharmaceutical Holdings Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lee’s Pharmaceutical Holdings Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$3.33. Based on the TTM, the Book Value Change Per Share is HK$0.06 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-0.92 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lee’s Pharmaceutical Holdings Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.000.3%0.000.3%0.011.0%0.108.7%0.086.9%
Usd Book Value Change Per Share0.010.7%0.010.7%-0.12-10.2%-0.01-1.0%0.022.1%
Usd Dividend Per Share0.000.2%0.000.2%0.010.5%0.010.6%0.010.9%
Usd Total Gains Per Share0.010.9%0.010.9%-0.11-9.8%0.00-0.4%0.033.0%
Usd Price Per Share0.20-0.20-0.21-0.40-0.71-
Price to Earnings Ratio53.95-53.95-18.72-23.16-21.53-
Price-to-Total Gains Ratio19.13-19.13--1.86-4.43-11.27-
Price to Book Ratio0.46-0.46-0.50-0.82-2.05-
Price-to-Total Gains Ratio19.13-19.13--1.86-4.43-11.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1472
Number of shares6793
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.01-0.01
Usd Total Gains Per Share0.010.00
Gains per Quarter (6793 shares)69.54-28.38
Gains per Year (6793 shares)278.14-113.52
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
163216268200-314-124
2125431546400-627-238
3188647824600-941-352
42508621102800-1254-466
5313107813801000-1568-580
6376129316581200-1881-694
7438150919361400-2195-808
8501172422141600-2508-922
9563194024921800-2822-1036
10626215527702000-3135-1150

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.05.00.078.3%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%18.05.00.078.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.00.07.069.6%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%18.05.00.078.3%

Fundamentals of Lee’s Pharmaceutical Holdings Ltd

About Lee’s Pharmaceutical Holdings Ltd

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China. It focuses on various disease areas, including cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates through Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells self-developed and generic pharmaceutical products, such as Nadroparin Calcium injection and Livaracine to treat blood clots and deep vein thrombosis; Yallaferon for viral infection; Slounase for hemostasis; Eyprotor for corneal ulcers; Treprostinil injection for pulmonary arterial hypertension; fondaparinux sodium injection for deep vein thrombosis; and Sodium Phenylbutyrate Granules to treat Urea cycle disorders. The Licensed-In Products segment trades in licensed-in pharmaceutical products, including Carnitene for the treatment of carnitine deficiency; Sancuso for chemotherapy induced nausea and vomiting; Bredinin to treat Immunosuppression in renal transplantation; Centraxal Plus for acute otitis media with tympanostomy tubes; Episil to treat oral mucositis pain; Ferplex to treat iron deficiency anemia; and Gaslon N for gastric ulcer and gastritis. This segment also offers Intrarosa for vulvovaginal atrophy; Adasuve for agitation associated with schizophrenia or bipolar I disorder in adults; Mictonorm for urinary incontinence; Natulan for Stage III and IV Hodgkin's disease; Omacor to treat Omega-3-acid ethyl esters; Zanidip and Rasilez for hypertension; Readyfusor for post-operative pain management; Teglutik to treat Amyotrophic lateral sclerosis; Trittico for insomnia/depression; Unidrox for urinary and respiratory tract infections; Dicoflor and VSL#3 for probiotics; and Zingo for topical local analgesics. The company was founded in 1994 and is headquartered in Sha Tin, Hong Kong.

Fundamental data was last updated by Penke on 2024-05-10 13:43:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Lee’s Pharmaceutical Holdings Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Lee’s Pharmaceutical Holdings Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Lee’s Pharmaceutical Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 1.6% means that $0.02 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lee’s Pharmaceutical Holdings Ltd:

  • The MRQ is 1.6%. The company is making a profit. +1
  • The TTM is 1.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.6%TTM1.6%0.0%
TTM1.6%YOY4.2%-2.6%
TTM1.6%5Y36.7%-35.1%
5Y36.7%10Y31.6%+5.2%
1.1.2. Return on Assets

Shows how efficient Lee’s Pharmaceutical Holdings Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lee’s Pharmaceutical Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.6% Return on Assets means that Lee’s Pharmaceutical Holdings Ltd generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lee’s Pharmaceutical Holdings Ltd:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.6%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.6%TTM0.6%0.0%
TTM0.6%YOY1.8%-1.3%
TTM0.6%5Y12.9%-12.3%
5Y12.9%10Y12.7%+0.2%
1.1.3. Return on Equity

Shows how efficient Lee’s Pharmaceutical Holdings Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lee’s Pharmaceutical Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.8% Return on Equity means Lee’s Pharmaceutical Holdings Ltd generated $0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lee’s Pharmaceutical Holdings Ltd:

  • The MRQ is 0.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.8%0.0%
TTM0.8%YOY2.7%-1.8%
TTM0.8%5Y19.1%-18.3%
5Y19.1%10Y17.9%+1.2%

1.2. Operating Efficiency of Lee’s Pharmaceutical Holdings Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Lee’s Pharmaceutical Holdings Ltd is operating .

  • Measures how much profit Lee’s Pharmaceutical Holdings Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lee’s Pharmaceutical Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lee’s Pharmaceutical Holdings Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY10.3%-10.3%
TTM-5Y6.8%-6.8%
5Y6.8%10Y16.3%-9.5%
1.2.2. Operating Ratio

Measures how efficient Lee’s Pharmaceutical Holdings Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.48 means that the operating costs are $1.48 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Lee’s Pharmaceutical Holdings Ltd:

  • The MRQ is 1.483. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.483. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.483TTM1.4830.000
TTM1.483YOY1.313+0.170
TTM1.4835Y1.323+0.160
5Y1.32310Y1.164+0.159

1.3. Liquidity of Lee’s Pharmaceutical Holdings Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Lee’s Pharmaceutical Holdings Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.01 means the company has $1.01 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Lee’s Pharmaceutical Holdings Ltd:

  • The MRQ is 1.012. The company is just able to pay all its short-term debts.
  • The TTM is 1.012. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.012TTM1.0120.000
TTM1.012YOY1.002+0.010
TTM1.0125Y1.192-0.179
5Y1.19210Y1.729-0.537
1.3.2. Quick Ratio

Measures if Lee’s Pharmaceutical Holdings Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lee’s Pharmaceutical Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.13 means the company can pay off $0.13 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lee’s Pharmaceutical Holdings Ltd:

  • The MRQ is 0.130. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.130. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.130TTM0.1300.000
TTM0.130YOY0.462-0.332
TTM0.1305Y0.666-0.535
5Y0.66610Y1.147-0.481

1.4. Solvency of Lee’s Pharmaceutical Holdings Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Lee’s Pharmaceutical Holdings Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lee’s Pharmaceutical Holdings Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.32 means that Lee’s Pharmaceutical Holdings Ltd assets are financed with 32.2% credit (debt) and the remaining percentage (100% - 32.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lee’s Pharmaceutical Holdings Ltd:

  • The MRQ is 0.322. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.322. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.322TTM0.3220.000
TTM0.322YOY0.308+0.013
TTM0.3225Y0.324-0.003
5Y0.32410Y0.276+0.048
1.4.2. Debt to Equity Ratio

Measures if Lee’s Pharmaceutical Holdings Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lee’s Pharmaceutical Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 45.6% means that company has $0.46 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lee’s Pharmaceutical Holdings Ltd:

  • The MRQ is 0.456. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.456. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.456TTM0.4560.000
TTM0.456YOY0.446+0.010
TTM0.4565Y0.483-0.027
5Y0.48310Y0.394+0.088

2. Market Valuation of Lee’s Pharmaceutical Holdings Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Lee’s Pharmaceutical Holdings Ltd generates.

  • Above 15 is considered overpriced but always compare Lee’s Pharmaceutical Holdings Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 53.95 means the investor is paying $53.95 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lee’s Pharmaceutical Holdings Ltd:

  • The EOD is 40.553. Based on the earnings, the company is overpriced. -1
  • The MRQ is 53.954. Based on the earnings, the company is expensive. -2
  • The TTM is 53.954. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD40.553MRQ53.954-13.400
MRQ53.954TTM53.9540.000
TTM53.954YOY18.715+35.238
TTM53.9545Y23.157+30.796
5Y23.15710Y21.529+1.629
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Lee’s Pharmaceutical Holdings Ltd:

  • The EOD is -13.644. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -18.153. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -18.153. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.644MRQ-18.153+4.509
MRQ-18.153TTM-18.1530.000
TTM-18.153YOY13.749-31.902
TTM-18.1535Y5.913-24.066
5Y5.91310Y30.638-24.725
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Lee’s Pharmaceutical Holdings Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Lee’s Pharmaceutical Holdings Ltd:

  • The EOD is 0.345. Based on the equity, the company is cheap. +2
  • The MRQ is 0.460. Based on the equity, the company is cheap. +2
  • The TTM is 0.460. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.345MRQ0.460-0.114
MRQ0.460TTM0.4600.000
TTM0.460YOY0.499-0.039
TTM0.4605Y0.823-0.363
5Y0.82310Y2.054-1.232
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Lee’s Pharmaceutical Holdings Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0620.0620%-0.918+1581%-0.090+245%0.188-67%
Book Value Per Share--3.3303.3300%3.268+2%3.717-10%3.244+3%
Current Ratio--1.0121.0120%1.002+1%1.192-15%1.729-41%
Debt To Asset Ratio--0.3220.3220%0.308+4%0.324-1%0.276+16%
Debt To Equity Ratio--0.4560.4560%0.446+2%0.483-5%0.394+16%
Dividend Per Share--0.0180.0180%0.041-56%0.058-69%0.078-77%
Eps--0.0280.0280%0.087-67%0.785-96%0.617-95%
Free Cash Flow Per Share---0.084-0.0840%0.119-171%-0.081-3%0.003-3010%
Free Cash Flow To Equity Per Share---0.084-0.0840%-0.100+18%0.002-3832%0.082-202%
Gross Profit Margin--1.0001.0000%1.0000%0.166+502%0.085+1083%
Intrinsic Value_10Y_max--2.299--------
Intrinsic Value_10Y_min---1.415--------
Intrinsic Value_1Y_max--0.052--------
Intrinsic Value_1Y_min---0.098--------
Intrinsic Value_3Y_max--0.292--------
Intrinsic Value_3Y_min---0.333--------
Intrinsic Value_5Y_max--0.696--------
Intrinsic Value_5Y_min---0.611--------
Market Cap677160259.200-33%900918074.790900918074.7900%959801604.200-6%1838343328.828-51%3260024557.851-72%
Net Profit Margin--0.0160.0160%0.042-62%0.367-96%0.316-95%
Operating Margin----0%0.103-100%0.068-100%0.163-100%
Operating Ratio--1.4831.4830%1.313+13%1.323+12%1.164+27%
Pb Ratio0.345-33%0.4600.4600%0.499-8%0.823-44%2.054-78%
Pe Ratio40.553-33%53.95453.9540%18.715+188%23.157+133%21.529+151%
Price Per Share1.150-33%1.5301.5300%1.630-6%3.122-51%5.528-72%
Price To Free Cash Flow Ratio-13.644+25%-18.153-18.1530%13.749-232%5.913-407%30.638-159%
Price To Total Gains Ratio14.380-33%19.13219.1320%-1.859+110%4.433+332%11.273+70%
Quick Ratio--0.1300.1300%0.462-72%0.666-80%1.147-89%
Return On Assets--0.0060.0060%0.018-69%0.129-96%0.127-95%
Return On Equity--0.0080.0080%0.027-69%0.191-96%0.179-95%
Total Gains Per Share--0.0800.0800%-0.877+1196%-0.033+141%0.266-70%
Usd Book Value--250956544.000250956544.0000%246285696.000+2%280117734.400-10%244832140.800+3%
Usd Book Value Change Per Share--0.0080.0080%-0.117+1581%-0.012+245%0.024-67%
Usd Book Value Per Share--0.4260.4260%0.418+2%0.476-10%0.415+3%
Usd Dividend Per Share--0.0020.0020%0.005-56%0.007-69%0.010-77%
Usd Eps--0.0040.0040%0.011-67%0.100-96%0.079-95%
Usd Free Cash Flow---6352640.000-6352640.0000%8935552.000-171%-6136729.600-3%231372.800-2846%
Usd Free Cash Flow Per Share---0.011-0.0110%0.015-171%-0.010-3%0.000-3010%
Usd Free Cash Flow To Equity Per Share---0.011-0.0110%-0.013+18%0.000-3832%0.011-202%
Usd Market Cap86676513.178-33%115317513.573115317513.5730%122854605.338-6%235307946.090-51%417283143.405-72%
Usd Price Per Share0.147-33%0.1960.1960%0.209-6%0.400-51%0.708-72%
Usd Profit--2137344.0002137344.0000%6564352.000-67%59136691.200-96%46524659.200-95%
Usd Revenue--134788352.000134788352.0000%157842944.000-15%153291980.800-12%140048576.000-4%
Usd Total Gains Per Share--0.0100.0100%-0.112+1196%-0.004+141%0.034-70%
 EOD+3 -5MRQTTM+0 -0YOY+14 -215Y+11 -2510Y+8 -28

3.2. Fundamental Score

Let's check the fundamental score of Lee’s Pharmaceutical Holdings Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1540.553
Price to Book Ratio (EOD)Between0-10.345
Net Profit Margin (MRQ)Greater than00.016
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.130
Current Ratio (MRQ)Greater than11.012
Debt to Asset Ratio (MRQ)Less than10.322
Debt to Equity Ratio (MRQ)Less than10.456
Return on Equity (MRQ)Greater than0.150.008
Return on Assets (MRQ)Greater than0.050.006
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Lee’s Pharmaceutical Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.929
Ma 20Greater thanMa 501.145
Ma 50Greater thanMa 1001.215
Ma 100Greater thanMa 2001.321
OpenGreater thanClose1.230
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Operating Income  221,565-64,585156,9801,821,6031,978,583-1,902,02376,560-83,919-7,359



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in HKD. All numbers in thousands.

Summary
Total Assets2,890,667
Total Liabilities930,069
Total Stockholder Equity2,038,955
 As reported
Total Liabilities 930,069
Total Stockholder Equity+ 2,038,955
Total Assets = 2,890,667

Assets

Total Assets2,890,667
Total Current Assets656,627
Long-term Assets2,234,040
Total Current Assets
Cash And Cash Equivalents 171,000
Net Receivables 84,590
Inventory 298,106
Total Current Assets  (as reported)656,627
Total Current Assets  (calculated)553,696
+/- 102,931
Long-term Assets
Property Plant Equipment 443,369
Goodwill 4,366
Intangible Assets 1,076,655
Long-term Assets  (as reported)2,234,040
Long-term Assets  (calculated)1,524,390
+/- 709,650

Liabilities & Shareholders' Equity

Total Current Liabilities648,818
Long-term Liabilities281,251
Total Stockholder Equity2,038,955
Total Current Liabilities
Short Long Term Debt 122,119
Accounts payable 74,147
Total Current Liabilities  (as reported)648,818
Total Current Liabilities  (calculated)196,266
+/- 452,552
Long-term Liabilities
Long term Debt 70,636
Capital Lease Obligations Min Short Term Debt11,385
Long-term Liabilities  (as reported)281,251
Long-term Liabilities  (calculated)82,021
+/- 199,230
Total Stockholder Equity
Retained Earnings 3,560,525
Total Stockholder Equity (as reported)2,038,955
Total Stockholder Equity (calculated)3,560,525
+/- 1,521,570
Other
Capital Stock29,442
Common Stock Shares Outstanding 588,835
Net Debt 21,755
Net Invested Capital 2,231,710
Net Working Capital 7,809
Property Plant and Equipment Gross 1,058,142



Balance Sheet

Currency in HKD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
> Total Assets 
23,139
48,434
44,589
49,396
46,842
52,620
86,598
107,910
208,566
311,713
410,076
796,531
1,165,655
1,369,380
1,851,128
2,061,397
2,324,524
3,006,553
3,640,241
3,252,921
3,636,898
2,782,028
2,890,667
2,890,6672,782,0283,636,8983,252,9213,640,2413,006,5532,324,5242,061,3971,851,1281,369,3801,165,655796,531410,076311,713208,566107,91086,59852,62046,84249,39644,58948,43423,139
   > Total Current Assets 
5,699
18,999
18,280
23,232
16,162
18,849
48,433
56,674
119,051
206,370
255,897
511,844
641,771
729,988
841,469
883,712
873,318
1,004,541
1,441,277
1,239,096
963,320
651,634
656,627
656,627651,634963,3201,239,0961,441,2771,004,541873,318883,712841,469729,988641,771511,844255,897206,370119,05156,67448,43318,84916,16223,23218,28018,9995,699
       Cash And Cash Equivalents 
296
14,064
4,201
10,527
3,876
4,815
6,254
17,520
60,482
120,104
134,494
333,902
379,062
392,912
394,147
504,975
449,406
429,594
775,130
414,535
277,529
189,301
171,000
171,000189,301277,529414,535775,130429,594449,406504,975394,147392,912379,062333,902134,494120,10460,48217,5206,2544,8153,87610,5274,20114,064296
       Short-term Investments 
0
1,346
8,331
2,012
2,042
29
12,372
6,674
2,012
56,517
42,899
177,313
178,437
124,352
115,903
209,693
5,826
207,298
410,136
39,336
0
0
0
00039,336410,136207,2985,826209,693115,903124,352178,437177,31342,89956,5172,0126,67412,372292,0422,0128,3311,3460
       Net Receivables 
0
2,714
3,530
6,811
6,493
7,918
21,255
25,580
29,710
61,061
84,232
111,547
142,495
197,863
107,780
108,121
120,912
215,198
195,777
237,078
168,323
111,278
84,590
84,590111,278168,323237,078195,777215,198120,912108,121107,780197,863142,495111,54784,23261,06129,71025,58021,2557,9186,4936,8113,5302,7140
       Inventory 
925
875
2,218
3,882
3,751
4,075
8,521
6,867
26,814
23,171
35,004
64,071
117,881
138,889
169,878
134,910
160,637
211,673
255,585
414,377
331,394
249,222
298,106
298,106249,222331,394414,377255,585211,673160,637134,910169,878138,889117,88164,07135,00423,17126,8146,8678,5214,0753,7513,8822,218875925
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,177,685
1,451,206
2,002,012
2,198,964
2,013,825
2,673,578
2,130,394
2,234,040
2,234,0402,130,3942,673,5782,013,8252,198,9642,002,0121,451,2061,177,685000000000000000
       Property Plant Equipment 
10,523
15,483
15,124
14,295
11,806
14,484
15,253
19,582
25,085
26,880
47,303
128,814
263,073
302,835
355,940
437,092
565,662
608,639
796,309
724,552
688,265
540,665
443,369
443,369540,665688,265724,552796,309608,639565,662437,092355,940302,835263,073128,81447,30326,88025,08519,58215,25314,48411,80614,29515,12415,48310,523
       Goodwill 
0
0
0
0
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
3,900
4,366
4,3663,9003,9003,9003,9003,9003,9003,9003,9003,9003,9003,9003,9003,9003,9003,9003,9003,9003,9000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
47,569
81,953
163,191
180,257
290,486
670,400
689,940
0
0
0
0
0000689,940670,400290,486180,257163,19181,95347,569000000000000
       Intangible Assets 
6,917
10,950
11,177
11,869
13,832
14,225
17,800
26,506
59,305
64,792
87,297
127,156
194,129
236,218
337,825
421,853
448,638
587,049
694,617
844,954
922,525
1,023,494
1,076,655
1,076,6551,023,494922,525844,954694,617587,049448,638421,853337,825236,218194,129127,15687,29764,79259,30526,50617,80014,22513,83211,86911,17710,9506,917
       Other Assets 
0
10,950
11,185
11,869
1,142
1,162
19,012
27,754
21,738
32,169
50,749
81,910
116,557
144,212
148,803
420,538
437,577
547,849
482,290
577,218
635,686
7,584
0
07,584635,686577,218482,290547,849437,577420,538148,803144,212116,55781,91050,74932,16921,73827,75419,0121,1621,14211,86911,18510,9500
> Total Liabilities 
19,076
13,061
15,547
12,517
11,182
19,431
25,773
22,575
63,836
70,365
97,745
203,252
313,597
370,513
334,300
426,681
527,592
768,484
1,162,803
1,137,543
1,172,320
857,921
930,069
930,069857,9211,172,3201,137,5431,162,803768,484527,592426,681334,300370,513313,597203,25297,74570,36563,83622,57525,77319,43111,18212,51715,54713,06119,076
   > Total Current Liabilities 
8,360
12,303
10,696
11,666
10,562
18,264
24,252
20,768
50,859
61,021
83,497
172,689
272,157
308,179
281,956
358,375
431,085
676,825
908,493
944,049
922,580
650,104
648,818
648,818650,104922,580944,049908,493676,825431,085358,375281,956308,179272,157172,68983,49761,02150,85920,76824,25218,26410,56211,66610,69612,3038,360
       Short-term Debt 
3,631
7,620
4,394
4,837
6,526
11,145
4,228
3,837
8,355
19,158
17,160
31,483
69,468
52,269
66,769
133,578
99,004
129,234
144,834
141,377
162,540
0
0
00162,540141,377144,834129,23499,004133,57866,76952,26969,46831,48317,16019,1588,3553,8374,22811,1456,5264,8374,3947,6203,631
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
69,618
52,269
67,940
133,578
99,004
129,234
144,834
141,377
162,540
76,727
122,119
122,11976,727162,540141,377144,834129,23499,004133,57867,94052,26969,618000000000000
       Accounts payable 
0
129
198
94
509
666
5,809
1,598
1,642
1,875
9,105
29,111
36,493
42,249
37,621
42,301
26,148
66,079
80,145
73,733
62,599
101,301
74,147
74,147101,30162,59973,73380,14566,07926,14842,30137,62142,24936,49329,1119,1051,8751,6421,5985,809666509941981290
       Other Current Liabilities 
0
4,554
5,295
5,128
3,527
6,453
14,215
15,333
40,733
41,250
56,710
111,532
166,046
213,661
147,753
168,510
271,106
451,633
624,587
665,690
684,802
465,245
0
0465,245684,802665,690624,587451,633271,106168,510147,753213,661166,046111,53256,71041,25040,73315,33314,2156,4533,5275,1285,2954,5540
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68,306
96,507
91,659
254,310
193,494
323,156
289,400
281,251
281,251289,400323,156193,494254,31091,65996,50768,306000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
868
1,001
516
782
13,364
7,502
91,959
79,936
0
079,93691,9597,50213,3647825161,00186800000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
17,029
26,779
46,812
51,476
67,305
95,991
90,877
240,946
185,992
231,197
209,464
0
0209,464231,197185,992240,94690,87795,99167,30551,47646,81226,77917,02900000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
101,344
129,726
207,837
285,955
295,057
415,825
468,092
558,489
620,262
0
0
00620,262558,489468,092415,825295,057285,955207,837129,726101,344000000000000
> Total Stockholder Equity
0
35,373
29,042
36,879
35,660
33,189
60,825
85,335
144,730
241,064
311,914
582,156
786,005
934,341
1,467,438
1,601,726
1,804,346
2,210,543
2,295,900
2,149,795
2,464,578
1,924,107
2,038,955
2,038,9551,924,1072,464,5782,149,7952,295,9002,210,5431,804,3461,601,7261,467,438934,341786,005582,156311,914241,064144,73085,33560,82533,18935,66036,87929,04235,3730
   Common Stock
0
14,461
14,461
17,311
17,311
17,311
20,656
20,764
22,506
23,292
23,489
26,055
26,912
27,236
29,340
29,503
29,547
29,601
29,396
29,406
29,442
29,442
0
029,44229,44229,40629,39629,60129,54729,50329,34027,23626,91226,05523,48923,29222,50620,76420,65617,31117,31117,31114,46114,4610
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 0000-247,786-177,421-146,042-94,950-66,861-42,064-39,001-38,593-28,806-21,720-18,676-14,541-13,159000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
717,925
721,154
724,868
731,771
714,146
714,813
720,091
720,091
0
0720,091720,091714,813714,146731,771724,868721,154717,92500000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
98,188
87,438
-47,540
-29,175
3,745
46,138
84,186
-153,723
-1,795,511
-2,369,405
0
0-2,369,405-1,795,511-153,72384,18646,1383,745-29,175-47,54087,43898,188000000000000



Balance Sheet

Currency in HKD. All numbers in thousands.




Cash Flow

Currency in HKD. All numbers in thousands.




Income Statement

Currency in HKD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,053,034
Cost of Revenue-501,723
Gross Profit551,311551,311
 
Operating Income (+$)
Gross Profit551,311
Operating Expense-1,060,393
Operating Income-7,359-509,082
 
Operating Expense (+$)
Research Development96,804
Selling General Administrative492,908
Selling And Marketing Expenses0
Operating Expense1,060,393589,712
 
Net Interest Income (+$)
Interest Income1,534
Interest Expense-11,277
Other Finance Cost-621
Net Interest Income-10,364
 
Pretax Income (+$)
Operating Income-7,359
Net Interest Income-10,364
Other Non-Operating Income Expenses0
Income Before Tax (EBT)30,785-7,359
EBIT - interestExpense = -11,277
16,698
27,975
Interest Expense11,277
Earnings Before Interest and Taxes (EBIT)042,062
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax30,785
Tax Provision-10,836
Net Income From Continuing Ops19,94919,949
Net Income16,698
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net010,364
 

Technical Analysis of Lee’s Pharmaceutical Holdings Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lee’s Pharmaceutical Holdings Ltd. The general trend of Lee’s Pharmaceutical Holdings Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lee’s Pharmaceutical Holdings Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Lee’s Pharmaceutical Holdings Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.18 < 1.18 < 1.23.

The bearish price targets are: 1.

Tweet this
Lee’s Pharmaceutical Holdings Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Lee’s Pharmaceutical Holdings Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Lee’s Pharmaceutical Holdings Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Lee’s Pharmaceutical Holdings Ltd. The current macd is -0.01692344.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Lee’s Pharmaceutical Holdings Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Lee’s Pharmaceutical Holdings Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Lee’s Pharmaceutical Holdings Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Lee’s Pharmaceutical Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) ChartLee’s Pharmaceutical Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Lee’s Pharmaceutical Holdings Ltd. The current adx is 33.38.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Lee’s Pharmaceutical Holdings Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Lee’s Pharmaceutical Holdings Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Lee’s Pharmaceutical Holdings Ltd. The current sar is 1.08663041.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Lee’s Pharmaceutical Holdings Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Lee’s Pharmaceutical Holdings Ltd. The current rsi is 45.93. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Lee’s Pharmaceutical Holdings Ltd Daily Relative Strength Index (RSI) ChartLee’s Pharmaceutical Holdings Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Lee’s Pharmaceutical Holdings Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lee’s Pharmaceutical Holdings Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Lee’s Pharmaceutical Holdings Ltd Daily Stochastic Oscillator ChartLee’s Pharmaceutical Holdings Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Lee’s Pharmaceutical Holdings Ltd. The current cci is 83.33.

Lee’s Pharmaceutical Holdings Ltd Daily Commodity Channel Index (CCI) ChartLee’s Pharmaceutical Holdings Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Lee’s Pharmaceutical Holdings Ltd. The current cmo is -2.24034728.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Lee’s Pharmaceutical Holdings Ltd Daily Chande Momentum Oscillator (CMO) ChartLee’s Pharmaceutical Holdings Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Lee’s Pharmaceutical Holdings Ltd. The current willr is -44.44444444.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Lee’s Pharmaceutical Holdings Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Lee’s Pharmaceutical Holdings Ltd Daily Williams %R ChartLee’s Pharmaceutical Holdings Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Lee’s Pharmaceutical Holdings Ltd.

Lee’s Pharmaceutical Holdings Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Lee’s Pharmaceutical Holdings Ltd. The current atr is 0.05037602.

Lee’s Pharmaceutical Holdings Ltd Daily Average True Range (ATR) ChartLee’s Pharmaceutical Holdings Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Lee’s Pharmaceutical Holdings Ltd. The current obv is 18,197,472.

Lee’s Pharmaceutical Holdings Ltd Daily On-Balance Volume (OBV) ChartLee’s Pharmaceutical Holdings Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Lee’s Pharmaceutical Holdings Ltd. The current mfi is 41.71.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Lee’s Pharmaceutical Holdings Ltd Daily Money Flow Index (MFI) ChartLee’s Pharmaceutical Holdings Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Lee’s Pharmaceutical Holdings Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Lee’s Pharmaceutical Holdings Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Lee’s Pharmaceutical Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.929
Ma 20Greater thanMa 501.145
Ma 50Greater thanMa 1001.215
Ma 100Greater thanMa 2001.321
OpenGreater thanClose1.230
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Lee’s Pharmaceutical Holdings Ltd with someone you think should read this too:
  • Are you bullish or bearish on Lee’s Pharmaceutical Holdings Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lee’s Pharmaceutical Holdings Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Lee’s Pharmaceutical Holdings Ltd

I send you an email if I find something interesting about Lee’s Pharmaceutical Holdings Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Lee’s Pharmaceutical Holdings Ltd.

Receive notifications about Lee’s Pharmaceutical Holdings Ltd in your mailbox!